Sonnet BioTherapeutics (SONN) Operating Margin (2010 - 2024)
Sonnet BioTherapeutics (SONN) operating margin from Jun 30, 2010 to Dec 31, 2024. The current Sonnet BioTherapeutics (SONN) operating margin is -285.00%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Sonnet BioTherapeutics (SONN)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -1584.00% | -97.33% |
| 2024 | -59250.00% | +372.99% |
| 2023 | -12526.67% | +47.77% |
| 2022 | -8477.14% | +62.18% |
| 2021 | -5227.08% | +9697.53% |
| 2019 | -53.35% | +205.30% |
| 2018 | -17.47% | +38.16% |
| 2017 | -12.65% | +101.30% |
| 2016 | -6.28% | -56.28% |
| 2015 | -14.37% | -22.60% |
| 2014 | -18.57% | -66.78% |
| 2013 | -55.88% | +47.79% |
| 2012 | -37.81% | -41.71% |
| 2011 | -64.86% | N/A |
| 2011 | -64.86% | -91.43% |
| 2010 | -757.14% | N/A |
| 2010 | -757.14% | N/A |
Comparison Sonnet BioTherapeutics (SONN) operating margin with competitors
Sonnet BioTherapeutics (SONN) operating margin is -285.00%.